Cronos Group Inc (CRON) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $2.67
• Market Cap: $1.06B
• P/E Ratio: 25.18
• EPS: $0.11
• 52-Week High: $3.43
• 52-Week Low: $1.60

Market Sentiment

Cronos Group Inc currently has a Bullish sentiment score of 0.30.

About Cronos Group Inc

Cronos Group Inc. is a prominent cannabinoid company headquartered in Toronto, Canada, that excels in the development and distribution of innovative cannabis products. Committed to pioneering advancements in cannabis science, the company emphasizes robust research and development to deliver unique offerings catering to both medical and recreational sectors. Through strategic partnerships and targeted investments, Cronos is poised to expand its global footprint, solidifying its role as a signi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cronos Group Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CRON pay dividends?

Cronos Group Inc (CRON) does not currently pay a regular dividend.

What is CRON's P/E ratio?

Cronos Group Inc has a price-to-earnings (P/E) ratio of 25.18.

What is CRON's market cap?

Cronos Group Inc (CRON) has a market capitalization of $1.06B with a current stock price of $2.67.